JP2001517655A - コレステロールエステル輸送タンパク質のインヒビターとして利用される4−フェニルテトラヒドロキノリン - Google Patents

コレステロールエステル輸送タンパク質のインヒビターとして利用される4−フェニルテトラヒドロキノリン

Info

Publication number
JP2001517655A
JP2001517655A JP2000512813A JP2000512813A JP2001517655A JP 2001517655 A JP2001517655 A JP 2001517655A JP 2000512813 A JP2000512813 A JP 2000512813A JP 2000512813 A JP2000512813 A JP 2000512813A JP 2001517655 A JP2001517655 A JP 2001517655A
Authority
JP
Japan
Prior art keywords
compound
formula
general formula
defined above
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000512813A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001517655A5 (cg-RX-API-DMAC7.html
Inventor
シユミツト,グンター
シユトルテフス,ユルゲン
レゲルス,ミヒヤエル
ブランデス,アルント
シユメク,カルステン
ブレム,クラウス−デイーター
ビシヨフ,ヒルマー
シユミツト,デルフ
Original Assignee
バイエル・アクチエンゲゼルシヤフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイエル・アクチエンゲゼルシヤフト filed Critical バイエル・アクチエンゲゼルシヤフト
Publication of JP2001517655A publication Critical patent/JP2001517655A/ja
Publication of JP2001517655A5 publication Critical patent/JP2001517655A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
JP2000512813A 1997-09-19 1998-09-07 コレステロールエステル輸送タンパク質のインヒビターとして利用される4−フェニルテトラヒドロキノリン Pending JP2001517655A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19741399A DE19741399A1 (de) 1997-09-19 1997-09-19 Tetrahydrochinoline
DE19741399.4 1997-09-19
PCT/EP1998/005658 WO1999015504A1 (de) 1997-09-19 1998-09-07 4-phenyltetrahydrochinoline als hemmer des cholesterolestertransferproteins

Publications (2)

Publication Number Publication Date
JP2001517655A true JP2001517655A (ja) 2001-10-09
JP2001517655A5 JP2001517655A5 (cg-RX-API-DMAC7.html) 2006-01-05

Family

ID=7842954

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000512813A Pending JP2001517655A (ja) 1997-09-19 1998-09-07 コレステロールエステル輸送タンパク質のインヒビターとして利用される4−フェニルテトラヒドロキノリン

Country Status (6)

Country Link
US (4) US6291477B1 (cg-RX-API-DMAC7.html)
EP (1) EP1017677A1 (cg-RX-API-DMAC7.html)
JP (1) JP2001517655A (cg-RX-API-DMAC7.html)
AU (1) AU9537098A (cg-RX-API-DMAC7.html)
DE (1) DE19741399A1 (cg-RX-API-DMAC7.html)
WO (1) WO1999015504A1 (cg-RX-API-DMAC7.html)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002525348A (ja) * 1998-09-25 2002-08-13 モンサント カンパニー コレステロールエステル輸送タンパク質活性阻害に有効な置換された多環アリールおよびヘテロアリール第三級ヘテロアルキルアミン
WO2006098394A1 (ja) * 2005-03-14 2006-09-21 Japan Tobacco Inc. 脂質吸収抑制方法および脂質吸収抑制剤
JP2008524145A (ja) * 2004-12-18 2008-07-10 バイエル・ヘルスケア・アクチェンゲゼルシャフト 4−シクロアルキル置換テトラヒドロキノリン誘導体および医薬としてのそれらの使用
WO2012005343A1 (ja) 2010-07-09 2012-01-12 第一三共株式会社 置換ピリジン化合物
WO2013103150A1 (ja) 2012-01-06 2013-07-11 第一三共株式会社 置換ピリジン化合物の酸付加塩
JP2015507023A (ja) * 2012-02-21 2015-03-05 セルジーン コーポレイション アミノスルホン化合物の調製のための不斉合成方法
JP2015526452A (ja) * 2012-08-24 2015-09-10 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 新規二環式ピリジン誘導体

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19741399A1 (de) * 1997-09-19 1999-03-25 Bayer Ag Tetrahydrochinoline
JPH11185506A (ja) * 1997-12-24 1999-07-09 Koito Mfg Co Ltd 車輌用前照灯
US7115279B2 (en) * 2000-08-03 2006-10-03 Curatolo William J Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
OA12619A (en) * 2001-06-21 2006-06-12 Pfizer Prod Inc Self-emulsifying formulations of cholesteryl estertransfer protein inhibitors.
KR100759635B1 (ko) 2001-06-22 2007-09-17 화이자 프로덕츠 인코포레이티드 비정질 약물의 흡착체의 약학 조성물
MXPA03011784A (es) 2001-06-22 2004-04-02 Pfizer Prod Inc Composiciones farmaceuticas de dispersiones de farmacos y polimeros neutros.
DE10148436A1 (de) * 2001-10-01 2003-04-17 Bayer Ag Tetrahydrochinoline
WO2003053359A2 (en) 2001-12-19 2003-07-03 Atherogenics, Inc. 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
CN1596240A (zh) 2001-12-19 2005-03-16 阿特罗吉尼克斯公司 查耳酮衍生物及其治疗疾病的用途
DE60320940D1 (de) * 2002-02-01 2008-06-26 Pfizer Prod Inc Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien
AR038375A1 (es) * 2002-02-01 2005-01-12 Pfizer Prod Inc Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo
AU2003283769A1 (en) 2002-12-20 2004-07-14 Pfizer Products Inc. Dosage forms comprising a cetp inhibitor and an hmg-coa reductase inhibitor
JP2007501218A (ja) * 2003-08-04 2007-01-25 ファイザー・プロダクツ・インク 非晶質薬物の吸着物および親油性ミクロ相形成物質の医薬組成物
CL2004001884A1 (es) 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
KR20070087197A (ko) 2003-09-26 2007-08-27 니뽄 다바코 산교 가부시키가이샤 잔여 리포프로테인 생산 저해 방법
WO2006065842A2 (en) * 2004-12-13 2006-06-22 Synta Pharmaceuticals Corp. 5,6,7,8-tetrahydroquinolines and related compounds and uses thereof
EP1828136A1 (de) * 2004-12-18 2007-09-05 Bayer HealthCare AG (5s)-3-[(s)-fluor(4-trifluoromethylphenyl)methyl]-5,6,7,8-tetrahydrochinolin-5-ol derivate und ihre verwendung als cetp-inhibitoren
EP1844078B1 (en) 2005-02-03 2016-09-28 Bend Research, Inc Pharmaceutical compositions with enhanced performance
US7737155B2 (en) 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
DE102006012548A1 (de) 2006-03-18 2007-09-20 Bayer Healthcare Ag Substituierte Chromanol-Derivate und ihre Verwendung
US20110243940A1 (en) 2008-12-16 2011-10-06 Schering Corporation Bicyclic pyranone derivatives and methods of use thereof
US20110245209A1 (en) 2008-12-16 2011-10-06 Schering Corporation Pyridopyrimidine derivatives and methods of use thereof
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
DE102013223272A1 (de) * 2013-11-14 2015-05-21 Bombardier Transportation Gmbh Verfahren zur Herstellung eines rohrförmigen Ausstattungselements für ein Schienenfahrzeug
CN117427074B (zh) * 2023-11-13 2026-07-28 山东第一医科大学(山东省医学科学院) 四氢喹啉醇作为铁死亡抑制剂在制备急性肾损伤药物中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169857A (en) 1988-01-20 1992-12-08 Bayer Aktiengesellschaft 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis
US5506219A (en) 1988-08-29 1996-04-09 E. R. Squibb & Sons, Inc. Pyridine anchors for HMG-CoA reductase inhibitors
NZ237097A (en) 1990-02-26 1993-12-23 Squibb & Sons Inc Pyridine derivatives substituted in the 3-position by a phosphinic moiety.
DE19707199A1 (de) 1997-02-24 1998-08-27 Bayer Ag Neues Verfahren zur Herstellung von Cycloalkanopyridinen
DE19627419A1 (de) * 1996-07-08 1998-01-15 Bayer Ag Cycloalkano-pyridine
US6207671B1 (en) * 1996-07-08 2001-03-27 Bayer Aktiengesellschaft Cycloalkano-pyridines
HRP970330B1 (en) * 1996-07-08 2004-06-30 Bayer Ag Cycloalkano pyridines
DE19709125A1 (de) 1997-03-06 1998-09-10 Bayer Ag Substituierte Chinoline
DE19741399A1 (de) * 1997-09-19 1999-03-25 Bayer Ag Tetrahydrochinoline

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002525348A (ja) * 1998-09-25 2002-08-13 モンサント カンパニー コレステロールエステル輸送タンパク質活性阻害に有効な置換された多環アリールおよびヘテロアリール第三級ヘテロアルキルアミン
JP2002525351A (ja) * 1998-09-25 2002-08-13 モンサント カンパニー コレステリルエステル伝達タンパク質活性を阻害するのに有用な(R)−キラルなハロゲン化された1−置換アミノ−(n+1)−アルカノール
JP2007112804A (ja) * 1998-09-25 2007-05-10 Pharmacia Corp コレステリルエステル伝達タンパク質活性を阻害するのに有用な(R)−キラルなハロゲン化された1−置換アミノ−(n+1)−アルカノール
JP2007126460A (ja) * 1998-09-25 2007-05-24 Pharmacia Corp コレステロールエステル輸送タンパク質活性阻害に有効な置換された多環アリールおよびヘテロアリール第三級ヘテロアルキルアミン
JP2008524145A (ja) * 2004-12-18 2008-07-10 バイエル・ヘルスケア・アクチェンゲゼルシャフト 4−シクロアルキル置換テトラヒドロキノリン誘導体および医薬としてのそれらの使用
WO2006098394A1 (ja) * 2005-03-14 2006-09-21 Japan Tobacco Inc. 脂質吸収抑制方法および脂質吸収抑制剤
WO2012005343A1 (ja) 2010-07-09 2012-01-12 第一三共株式会社 置換ピリジン化合物
US9187450B2 (en) 2010-07-09 2015-11-17 Daiichi Sankyo Company, Limited Substituted pyridine compound
WO2013103150A1 (ja) 2012-01-06 2013-07-11 第一三共株式会社 置換ピリジン化合物の酸付加塩
JPWO2013103150A1 (ja) * 2012-01-06 2015-05-11 第一三共株式会社 置換ピリジン化合物の酸付加塩
US9321747B2 (en) 2012-01-06 2016-04-26 Daiichi Sankyo Company, Limited Acid addition salt of substituted pyridine compound
JP2015507023A (ja) * 2012-02-21 2015-03-05 セルジーン コーポレイション アミノスルホン化合物の調製のための不斉合成方法
JP2015526452A (ja) * 2012-08-24 2015-09-10 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 新規二環式ピリジン誘導体

Also Published As

Publication number Publication date
US6897317B2 (en) 2005-05-24
US6562976B2 (en) 2003-05-13
EP1017677A1 (de) 2000-07-12
US6291477B1 (en) 2001-09-18
US20020042515A1 (en) 2002-04-11
AU9537098A (en) 1999-04-12
US20020165252A1 (en) 2002-11-07
DE19741399A1 (de) 1999-03-25
US20030232990A1 (en) 2003-12-18
WO1999015504A1 (de) 1999-04-01

Similar Documents

Publication Publication Date Title
US6291477B1 (en) Tetrahydroquinolines, processes for their preparation, pharmaceutical compositions containing them, and their use to prevent or treat hyperlipoproteinaemia
JP4146531B2 (ja) シクロアルカノ−ピリジン類
AU722365B2 (en) Bicyclic-fused pyridines
JP4157178B2 (ja) 複素環式−縮合ピリジン類
US6387929B1 (en) 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein
JP2001513790A (ja) 5−オキシ置換キノリン類およびコレステロールエステル輸送タンパク質阻害剤としてのそれらの使用
JPH09255574A (ja) 2−アリール−置換ピリジン類
US6207671B1 (en) Cycloalkano-pyridines
JP2001517646A (ja) ベンジルビフェニルおよび類似化合物、ならびに動脈硬化症および異脂肪血症を治療するためのそれらの適用
US6121330A (en) 5-Hydroxyalkyl substituted phenyls and their use in medicaments for the treatment of arteriosclerosis and hyperlipoproteinaemia
AU730109B2 (en) 2-amino-substituted pyridines which can be used for the treatment of arteriosclerosis and hyperclipoproteinaemia
JP2005508341A (ja) 3−ヒドロキシ−(4−トリフルオロメチルフェニル)−メチル−7−スピロシクロブチル−5,6,7,8−テトラヒドロキノリン−5−オール誘導体およびコレステロールエステル転送タンパク質(cetp)阻害剤としてのその使用
EP1828137B1 (de) 4-cycloalkyl-substituierte tetrahydrochinolinderivate und deren verwendung als medikamente
MXPA99007244A (en) 2-amino substituted pyridines for use in the treatment of arteriosclerosis and hyperlipoproteinaemia

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050622

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050622

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20080328

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A132

Effective date: 20090303

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090528

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090604

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20090819

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100119